Skip to main content
SpringerLink
Log in

The occurrence of opportunistic non-Hodgkin’s lymphomas in the setting of infection with the human immunodeficiency virus

  • Chapter
Annals of Oncology

  • 78 Accesses

Summary

The incidence of non-Hodgkin’s lymphoma (NHL) has increased by over 50% in the United States since 1973. There is epidemiologic evidence that some of this increase is the result of AIDS-related lymphoma and that this component is increasing. Prolonged survival in the setting of a variety of immunodeficiency states is associated with an increased incidence of NHL. The development of antiretroviral therapy and improved therapy for the complications of AIDS has resulted in prolonged survival of patients with AIDS. As these patients survive longer with profound immunodeficiency, they have an increased cumulative risk of developing NHL. This may result in even more AIDS-related NHL in the future than predicted from current epidemiological studies. An increased understanding of the pathogenesis of AIDS-related NHL may lead to means of preventing their occurrence. Also, therapies that may prevent immunodeficiency from developing in HIV-infected patients may reduce the likelihood of NHL developing. Current efforts at treating these lymphomas are aimed at preventing the myelosuppression and immunosuppression associated with current regimens, lymphoma relapses within the central nervous system, and the opportunistic infections associated with treatment of these tumors. Ultimately, the best means of preventing the development of these lymphomas is by preventing infection with HIV.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gottlieb MS, Schroff R, Schanker HM et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men. N Engl J Med 1981; 305: 1425–31.

    Article  PubMed  CAS  Google Scholar 

  2. Hymes KB, Greene FB, Marcus A et al. Kaposi’s sarcoma in homosexual men–A report of eight cases. Lancet 1981; 2: 598–600.

    Article  PubMed  CAS  Google Scholar 

  3. Masur H, Michelis MA, Greene JB et al. An outbreak of community-acquired Pneumocystis carinii pneumonia: Initial Manifestation of cellular immune dysfunction. N Engl J Med 1981; 305: 1431–8.

    Article  PubMed  CAS  Google Scholar 

  4. Siegal FP, Lopez C, Hammer GS et al. Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med 1981; 305: 1439–44.

    Article  PubMed  CAS  Google Scholar 

  5. Doll DC, List AF. Burkitt’s lymphoma in a homosexual. Lancet 1982; 1: 1026–7.

    Article  PubMed  CAS  Google Scholar 

  6. Bermudez MA, Grant K, Rodvien R et al. Non-Hodgkin’s lymphoma in a population with or at risk for acquired immunodeficiency syndrome: Indications for intensive chemotherapy. Am J Med 1989; 86: 71–6.

    Article  PubMed  CAS  Google Scholar 

  7. Kalter SP, Riggs SA, Cabanillas F et al. Aggressive non-Hodgkin’s lymphomas in immunocompromised homosexual males. Blood 1985; 66: 655–9.

    PubMed  CAS  Google Scholar 

  8. Kaplan LD, Abrams DI, Feigal E et al. AIDS-associated non-Hodgkins lymphoma in San Francisco. JAMA 1989; 261: 719–24.

    Article  PubMed  CAS  Google Scholar 

  9. Knowles DM, Chamulak GA, Subar M et al. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS): The New York University Medical Center experience with 105 patients (1981–1986). Ann Intern Med 1988; 108: 744–53.

    Article  PubMed  CAS  Google Scholar 

  10. Levine AM, Gill PS, Meyer PR et al. Retrovirus and malignant lymphoma in homosexual men. JAMA 1985; 254: 1921–5.

    Article  PubMed  CAS  Google Scholar 

  11. Lowenthal DA, Straus DJ, Campbell SW et al. AIDS-related lymphoid neoplasia: The Memorial Hospital experience. Cancer 1988; 61: 2325–37.

    Article  PubMed  CAS  Google Scholar 

  12. Ziegler JL, Miner RC, Rosenbaum E et al. Outbreak of Burkitt’s-like lymphoma in homosexual men. Lancet 1982; 2: 631–3.

    Article  PubMed  CAS  Google Scholar 

  13. Ziegler JL, Becksted JA, Volberding PA et al. Non-Hodgkin’s lymphoma in 90 homosexual men: Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med 1984; 311: 565–70.

    Article  PubMed  CAS  Google Scholar 

  14. Centers for Disease Control. Revision of the case definition of acquired immunodeficiency syndrome for national reporting–United States. MMWR 1985; 34: 373–373.

    Google Scholar 

  15. Biggar RJ, Burnett W, Mikl J et al. Cancer among New York men at risk of acquired immunodeficiency syndrome. Int J Cancer 1989; 43: 979–85.

    Article  PubMed  CAS  Google Scholar 

  16. Biggar RJ, Horm J, Goedert JJ et al. Cancer in a group at risk of acquired immunodeficiency syndrome (AIDS) through 1984. Am J Epidemiol 1987; 126: 578–86.

    PubMed  CAS  Google Scholar 

  17. Centers for Disease Control. HIV/AIDS Surveillance Report. 1990; January, 1990: 1–22.

    Google Scholar 

  18. The Non-Hodgkin’s Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin’s lymphomas: Summary and description of a working formulation for clinical usage. Cancer 1982; 49: 2112–35.

    Article  Google Scholar 

  19. Gill PS, Levine AM, Krailo M et al. AIDS-related malignant lymphoma: Results of prospective treatment trials. J Clin On-col 1987; 5: 1322–8.

    CAS  Google Scholar 

  20. Filipovich AH, Heinitz KJ, Robison LL et al. The immunodeficiency cancer registry: A research resource. Am J Pediatr Hematol Oncol 1987; 9: 183–4.

    Article  PubMed  CAS  Google Scholar 

  21. Kersey JH, Spector BD, Good RA. Primary immunodeficiency diseases and cancer: The immunodeficiency-cancer registry. Int J Cancer 1973; 12: 333–47.

    Article  PubMed  CAS  Google Scholar 

  22. Perry GSI, Spector BD, Schuman LM et al. The WiskottAldrich syndrome in the United States and Canada (18921979). J Pediatr 1980; 97: 72–8.

    Article  PubMed  Google Scholar 

  23. Frizzera G, Rosai J, Dehner LP et al. Lymphoreticular dis orders in primary immunodeficiencies: New findings based on an up-to-date histologic classification of 35 cases. Cancer 1980; 46: 692–99.

    Article  PubMed  CAS  Google Scholar 

  24. Cotelingam JD, Witebsky FG, Hsu SM et al. Malignant Lymphoma in patients with the Wiskott-Aldrich syndrome. Cancer Invest 1985; 3: 515–22.

    Article  PubMed  CAS  Google Scholar 

  25. Penn I. Tumors arising in organ transplant recipients. Adv Cancer Res 1978; 28: 31–61.

    Article  PubMed  CAS  Google Scholar 

  26. Penn I. Kaposi’s sarcoma in organ transplant recipients. Transplantation 1979; 27: 8–11.

    Article  PubMed  CAS  Google Scholar 

  27. Penn I. The occurrence of malignant tumors in immunosuppressed states. Prog Allergy 1986; 37: 259–300.

    PubMed  CAS  Google Scholar 

  28. The Surveillance Program Division of Cancer Prevention and Control National Cancer Institute. Table II-1. Summary of 15 year trends: Age adjusted cancer incidence rates. In: Ries LAG, Barrett MJ and Labbe RR (eds). Cancer Statistics Review: 1973–1987. 1990: 11–4.

    Google Scholar 

  29. Hardell L, Eriksson M, Lenner P et al. Malignant lymphoma and exposure to chemicals, especially organic solvents, chlorophenols and phenoxy acids: A case-control study. Br J Cancer 1981; 43: 169–76.

    Article  PubMed  CAS  Google Scholar 

  30. Woods JS, Polissar L, Severson RK et al. Soft tissue sarcoma and non-Hodgkin’s lymphoma in relation to phenoxyherbicide and chlorinated phenol exposure in western Washington. JNCI 1987; 78: 899–910.

    PubMed  CAS  Google Scholar 

  31. Burmeister LF, Everett GD, Van Lier SF et al. Selected cancer mortality and farm practices in Iowa. Am J Epidemiol 1983; 118: 72–7.

    PubMed  CAS  Google Scholar 

  32. Hoar SK, Blair A, Holmes FF et al. Agricultural herbicide use and risk of lymphoma and soft-tissue sarcoma. JAMA 1986; 256: 1141–7.

    Article  PubMed  CAS  Google Scholar 

  33. Cantor KP. Farming and mortality from non-Hodgkin’s lymphoma: A case-control study. Int J Cancer 1982; 29: 239–47.

    Article  PubMed  CAS  Google Scholar 

  34. Wigle DT, Semenciw RM, Wilkins K et al. Mortality study of Canadian male farm operators: Non-Hodgkin’s lymphoma mortality and agricultural practices in Saskatchewan. JNCI 1990; 82: 575–82.

    Article  PubMed  CAS  Google Scholar 

  35. Persson B, Dahlander A-M, Fredriksson M et al. Malignant lymphomas ans occupational exposures. Br J Ind Med 1989; 46: 516–20.

    PubMed  CAS  Google Scholar 

  36. Cartwright RA, McKinney PA, O’Brien C et al. Non-Hodgkin’s lymphoma: A case control epidemiologic study in Yorkshire. Leukemia Res 1988; 12: 81–8.

    Article  CAS  Google Scholar 

  37. Ott MG, Teta MJ, Greenberg HL. Lymphatic and hematopoietic tissue cancer in a chemical manufacturing environment. Am J Ind Med 1989; 16: 631–43.

    Article  PubMed  CAS  Google Scholar 

  38. Olsson H, Brandt L. Risk of non-Hodgkin’s lymphoma among men occupationally exposed to organic solvents. Scan J Work Environ Health 1988; 14: 246–51.

    Article  CAS  Google Scholar 

  39. Blakley BR, Schiefer BH. The effect of topically applied nbutylester of 2,4-dichlorophenoxyacetic acid on the immune response in mice. J Appl Toxicol 1986; 6: 291–5.

    Article  PubMed  CAS  Google Scholar 

  40. Blakley BR. The effect of oral exposure to the n-butylester of 2,4-dichlorophenoxyacetic acid on the immune response in mice. Int J Immunopharmac 1986; 8: 93–9.

    Article  CAS  Google Scholar 

  41. Blakley BR, Blakley SM. The effect of prenatal exposure to the n-butylester of 2,4-dichlorophenoxyacetic acid (2,4-D) on the immune response in mice. Teratology 1986; 33: 15–20.

    Article  PubMed  CAS  Google Scholar 

  42. Harris MW, Moore JA, Vos JG et al. General biological effects of TCDD in laboratory animals. Environ Health Perspect 1973; 5: 101–9.

    Article  PubMed  CAS  Google Scholar 

  43. Vos JG, Moore JA, Zinkl JG. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the immune system of laboratory animals. Environ Health Perspect 1973; 5: 149–62.

    Article  PubMed  CAS  Google Scholar 

  44. Burmeister LE Cancer mortality in Iowa farmers, 1971–8. JNCI 1981; 66: 461–4.

    Google Scholar 

  45. Cantor KP, Fraumeni JF Jr. Distribution of non-Hodgkin’s lymphoma in the United States between 1950 and 1975. Cancer Res 1980; 40: 2645–52.

    PubMed  CAS  Google Scholar 

  46. Pearce NE, Smith AH, Fisher DO. Malignant lymphoma and multiple myeloma linked with agricultural occupations in a New Zealand cancer registry-based study. Am J Epidemiol 1985; 121: 225–37.

    PubMed  CAS  Google Scholar 

  47. Pearce NE, Sheppard RA, Smith AH et al. Non-Hodgkin’s lymphoma and farming: An expanded case-control study. Int J Cancer 1987; 39: 155–61.

    Article  PubMed  CAS  Google Scholar 

  48. Johnson ES, Fischman HR, Matanoski GM et al. Cancer mortality among white males in the meat industry. J Occup Med 1986; 28: 23–32.

    Article  PubMed  CAS  Google Scholar 

  49. Francis DP, Essex M, Cotter SM et al. Epidemiological association between virusnegative feline leukemia and the horizontally transmitted feline leukemia cirus. Cancer Lett 1981; 12: 37–42.

    Article  PubMed  CAS  Google Scholar 

  50. Fraumeni JF Jr. Epidemiological studies of cancer. In: Griffin AC and Shaw CR (eds). Carcinogens: Identification and Mechanisms of Action. New York: Raven Press 1979; 51–63.

    Google Scholar 

  51. Lemp GF, Payne SF, Neal D et al. Survival trends for patients with AIDS. JAMA 1990; 263: 402–6.

    Article  PubMed  CAS  Google Scholar 

  52. Allegra CJ, Chabner BA, Tuazon CU et al. Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. N Engl J Med 1987; 317: 978–85.

    Article  PubMed  CAS  Google Scholar 

  53. Kovacs JA, Ng VL, Masur H et al. Diagnosis of Pneumocystis carinii pneumonia: Improved detection in sputum with use of monoclonal antibodies. N Engl J Med 1988; 318: 589–93.

    Article  PubMed  CAS  Google Scholar 

  54. Zaman MK, Wooten OJ, Suprahmanya B et al. Rapid noninvasive diagnosis of Pneumocystis carinii from induced liquefied sputum. Ann Intern Med 1988; 109: 7–10.

    Article  PubMed  CAS  Google Scholar 

  55. Girard P-M, Gaudebout C, Lottin P et al. Prevention of Pneumocystis carinii pneumonia relapse by pentamidine aerosol in zidovudine-treated AIDS patients. Lancet 1989; 1: 1348–53.

    Article  PubMed  CAS  Google Scholar 

  56. Golden JA, Hollander H, Chernoff D et al. Prevention of Pneumocystis carinii pneumonia by inhaled pentamidine. Lancet 1989; 1: 654–7.

    Article  PubMed  CAS  Google Scholar 

  57. Fischl MA, Richman DD, Grieco MH et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled trial. N Engl J Med 1987; 317: 185–91.

    Article  PubMed  CAS  Google Scholar 

  58. Montgomery AB, Leoung GS, Wardlaw LA et al. Effect of zidovudine on mortality rates and Pneumocystis carinii (PCP) incidence in AIDS and ARC patients on aerosol pentamidine. Am Rev Resp Dis 1989; 139: A250.

    Google Scholar 

  59. New York State Department of Health. Survival of AIDS cases by risk factors and year of diagnosis. In: AIDS in New York State through 1989. Albany, N.Y.: New York State Department of Health 1990; 92–93.

    Google Scholar 

  60. Pluda JM, Yarchoan R, Jaffe ES et al. Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy. Ann Int Med 1990; 113: 276–82.

    Article  PubMed  CAS  Google Scholar 

  61. Gill PS, Loureiro C, Bernstein-Singer M et al. Clinical effect of glucocorticoids on Kaposi’s sarcoma related to the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1989; 110: 937–40.

    Article  PubMed  CAS  Google Scholar 

  62. Real FX, Krown SE, Koziner B. Steroid-induced development of Kaposi’s sarcoma in a homosexual man with Burkitt’s lymphoma. Am J Med 1986; 80: 119–22.

    Article  PubMed  CAS  Google Scholar 

  63. Burroughs Wellcome Company. Lifetime Bioassay Studies. In: (eds) Comprehensive Information for Investigators, RETROVIR. Research Triangle Park, North Carolina: Burroughs Wellcome Company; 1989: 48.

    Google Scholar 

  64. Ayers KM, Prcclinical toxicology of zidovudine: An overview. Am J Med 1988; 85: 186–8.

    PubMed  CAS  Google Scholar 

  65. Pelicci P-G, Knowles DM II, Arlin ZA et al. Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immune deficiency syndrome-related lymphoproliferative disorders. J Exp Med 1986; 164: 2049–76.

    Article  PubMed  CAS  Google Scholar 

  66. Lippman SM, Volk JR, Spier CM et al. Clonal ambiguity of human immunodeficiency virus-associated lymphomas. Arch Pathol Lab Med 1988; 122: 128–32.

    Google Scholar 

  67. Egerter DA, Beckstead JH. Malignant lymphomas in the acquired immunodeficiency syndrome: Additional evidence for a B-cell origin. Arch Pathol Lab Med 1988; 112: 602–6.

    PubMed  CAS  Google Scholar 

  68. Pahwa S, Pahwa R, Saxinger C et al. Influence of the human T-lymphotropic virus/lymphadenopathy-associated virus on functions of human lymphocytes: Evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations. Proc Natl Acad Sci USA. 1985; 82: 8198–202.

    Article  PubMed  CAS  Google Scholar 

  69. Schnittman SM, Lane HC, Higgins SE et al. Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus. Science 1986; 233: AIDS-lymphoma pathogenesis.

    Google Scholar 

  70. Yarchoan R, Redfield RR, Broder S. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibodyproducing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, Type III/lymphadenopathy-associated virus. J Clin Invest 1986; 78: 439–47.

    Article  PubMed  CAS  Google Scholar 

  71. Birx DL, Redfield RR, Tosato G. Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders. N Engl J Med 1986; 314: 874–9.

    Article  PubMed  CAS  Google Scholar 

  72. Ganser A, Carlo-Stella C, Bartram CR et al. Establishment of two Epstein-Barr virus negative Burkitt cell lines from a patient with AIDS and B-cell lymphoma. Blood 1988; 72: 1255–60.

    PubMed  CAS  Google Scholar 

  73. Groopman JE, Sullivan JL, Mulder C et al. Pathogenesis of B cell lymphoma in a patient with AIDS. Blood 1986; 67: 6125.

    Google Scholar 

  74. Subar M, Neri A, Inghirami G et al. Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma. Blood 1988; 72: 667–71.

    PubMed  CAS  Google Scholar 

  75. McGrath MS, Feigal E, Reyes GR et al. Evidence that Epstein-Barr virus (EBV) may infect B lymphoma cells after transformation in the small subgroup of AIDS-associated lymphomas (A-NHL) that are ABV positive. IV International Conference on AIDS, Stochholm, Sweden, June 12–16. 1988; 325.

    Google Scholar 

  76. Whang-Peng J, Lee EC, Sieverts H et al. Burkitt’s lymphoma in AIDS: Cytogenetic study. Blood 1984; 63: 818–22.

    PubMed  CAS  Google Scholar 

  77. Chaganti RSK, Jhanwar SC, Koziner B et al. Specific translocations characterize Burkitt’s-like lymphoma of homosexual men with the acquired immunodeficiency syndrome. Blood 1983; 61: 1269–72.

    Google Scholar 

  78. Haluska FG, Russo G, Kant J et al. Molecular resemblance of an AIDS-associated lymphoma and endemic Burkitt lymphomas: Implications for their pathogenesis. Proc Natl Acad Sci USA 1989; 86: 8907–11.

    Article  PubMed  CAS  Google Scholar 

  79. Rechavi G, Ben-Bassat I, Berkowicz M et al. Molecular analysis of Burkitt’s leukemia in two hemophilic brothers with AIDS. Blood 1987; 70: 1713–7.

    PubMed  CAS  Google Scholar 

  80. Klein G. Multiple phenotypic consequences of the Ig/Myc translocation in B-cell-derived tumors. Genes Chrom Cancer 1989; 1: 3–8.

    Article  PubMed  CAS  Google Scholar 

  81. Friedman-Kien AE, Salzman BR, Cao Y et al. Kaposi’s sarcoma in HIV-negative homosexual men. Lancet 1990; 335: 168–9.

    Article  PubMed  CAS  Google Scholar 

  82. Beral V. Peterman TA, Berkelman RL et al. Kaposi’s sarcoma among persons with AIDS: a sexually transmitted infection. Lancet 1990; 335: 123–8.

    Article  PubMed  CAS  Google Scholar 

  83. McManaway ME, Neckers LM, Loke SL et al. Tumor-specific inhibition of lymphoma growth by ab antisense oligodeoxynucleotide. Lancet 1990; 335: 808–11.

    Article  PubMed  CAS  Google Scholar 

  84. Saxon A, Stevens RH, Golde DW. T-lymphocyte variant of hairy-cell leukemia. Ann Intern Med 1978; 88: 323–6.

    Article  PubMed  CAS  Google Scholar 

  85. Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M et al. A new subtype of human T-cell leukemia virus (HTLV II) associated with a T-cell variant of hairy cell leukemia. Science 1982; 218: 571–3.

    Article  PubMed  CAS  Google Scholar 

  86. Rosenblatt JD, Golde DW, Wachsman W et al. A second isolate of HTLV-II associated with atypical hairy-cell leukemia. N Engl J Med 1986; 315: 372–7.

    Article  PubMed  CAS  Google Scholar 

  87. Uchiyama T, Yodoi J, Sagawa K et al. Adult T-cell leukemia: Clinical and hematologic features of 16 cases. Blood 1977; 50: 481–92.

    PubMed  CAS  Google Scholar 

  88. Poiesz BF, Ruscetti FW, Gazdar AF et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980; 77: 7415–9.

    Article  PubMed  CAS  Google Scholar 

  89. Bunn PA, Schlechter GP, Jaffe E et al. Clinical course of retrovirus-associated adult t-cell lymphoma in the United States. N Engl J Med 1983; 309: 257–64.

    Article  PubMed  Google Scholar 

  90. Broder S, Bunn PA, Jaffe ES et al. T-cell lymphoproliferative syndrome associated with human T-cell leukemia/lymphoma virus. Ann Int Med 1984; 100: 543–57.

    Article  PubMed  CAS  Google Scholar 

  91. Tanaka A, Takahashi C, Yamaoka S et al. Oncogenic transformation by the tax gene of human T-cell leukemia virus type I in vitro. Proc Natl Acad Sci USA 1990; 87: 1071–5.

    Article  PubMed  CAS  Google Scholar 

  92. Waldmann TA, Junghans RP. Interleukin-2 receptor directed therapy: a model for immune intervention. AIDS Res Hum Retroviruses 1990; 6–96.

    Google Scholar 

  93. Mann DL, DeSantis P, Mark G et al. HTLV I-associated B-cell CLL: Indirect role for retrovirus in leukemogenesis. Science 1987; 236: 1103–6.

    Article  PubMed  CAS  Google Scholar 

  94. Bartholomew C, Saxinger C, Clark JW et al. Transmission of HTLV I and HIV among homosexual men in Trinidad. JAMA 1987; 257: 2604–8.

    Article  PubMed  CAS  Google Scholar 

  95. Robert-Guroff M, Weiss SH, Giron JA et al. Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region. JAMA 1986; 255: 3133–7.

    Article  PubMed  CAS  Google Scholar 

  96. Hahn RA, Onorato IM, Jones S et al. Prevalence of HIV infection among intravenous drug users in the United States. JAMA 1989; 261: 2677–84.

    Article  PubMed  CAS  Google Scholar 

  97. Zack JA, Cann AJ, Lugo JP et al. HIV-1 production from infected peripheral blood T cells after HTLV-I induced mito-genic stimulation. Science 1988; 240: 1026–9.

    Article  PubMed  CAS  Google Scholar 

  98. Rimsky L, Hauber J, Dukovich M et al. Functional replacement of the HIV-I rev protein by the HTLV-1 rex protein. Nature 1988; 335: 738–40.

    Article  PubMed  CAS  Google Scholar 

  99. Harper ME, Kaplan MH, Marselle LM et al. Concomitant infection with HTLV-I and HTLV-III in a patient with T8 lymphoproliferative disease. N Engl J Med 1988; 315: 1073–8.

    Article  Google Scholar 

  100. Volberding PA, Lagakos SW, Koch MA et al. Zidovudine in asymptomatic human immunodeficiency virus infection: A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. N Engl J Med 1990; 322: 941–9.

    Article  PubMed  CAS  Google Scholar 

  101. Fischl MA, Richman DT, Hansen N et al. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection: A double-blind, placebo-controlled trial. Ann Int Med 1990; 112: 727–37.

    Article  PubMed  CAS  Google Scholar 

  102. Neudorf SML, Filipovich AH, Kersey JH. Immunoreconstitution by bone marrow transplantation decreases lymphoproliferative malignancies in Wiskott-Aldrich and severe combined immune deficiency syndromes. In: Purtilo DT (eds). Immune Deficiency and Cancer: Epstein-Barr Virus and Lymphoproliferative Malignancies. New York: Plenum Medical Book Company 1984; 471–80.

    Chapter  Google Scholar 

  103. Till MA, Ghetie V, Gregory T et al. HIV-infected cells are killed by rCD4-ricin A chain. Science 1988; 242: 1166–8.

    Article  PubMed  CAS  Google Scholar 

  104. Berger EA, Clouse KA, Chaudhary VK et al. CD4-Pseudomonas exotoxin hybrid blocks the spread of human immunodeficiency virus infection in vitro and is active against cells expressing the envelope glycoproteins from diverse primate immunodeficiency retroviruses. Proc Natl Acad Sci USA 1989; 86: 9539–43.

    Article  PubMed  CAS  Google Scholar 

  105. Kaplan LD, Kahn JO, Grossberg H et al. Chemotherapy with and without granulocytemacrophage colony stimulating factor (rGM-CSF) in patients with AIDS-associated non-Hodgkin’s lymphoma (NHL). V International Conference on AIDS: The Scientific and Social Challenge, Montreal, Canada, June 4–9. 1989 (abstract): 334.

    Google Scholar 

  106. Walsh C, Wernz J, Laubenstein L et al. Phase I study of mBACOD and GM-CSF in AIDS-associated non-Hodgkin’s lymphoma (NHL): Preliminary results. Blood 1989 (abstract); 74 (Suppl 1): 126a.

    Google Scholar 

  107. Yarchoan R, Mitsuya H, Thomas RV et al. In vivo activity against HIV and favorable toxicity profile of 2’,3’-dideoxyinosine. Science 1989; 245: 412–5.

    Article  PubMed  CAS  Google Scholar 

  108. Lambert JS, Seidlin M, Reichman RC et al. 2’,3’-dideoxyinosine (ddl) in patients with the acquired immunodeficiency syndrome or the AIDS-related complex: A phase I trial. N Engl J Med 1990; 322: 1333–40.

    Article  PubMed  CAS  Google Scholar 

  109. Cooley TP, Kunches LM, Saunders CA et al. Once-daily administration of 2’,3’-dideoxyinosine (ddl) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. N Engl J Med 1990; 322: 1340–5.

    Article  PubMed  CAS  Google Scholar 

  110. Levine AM, Wernz JC, Kaplan L et al. Low dose chemotherapy with CNS prophylaxis and zidovudine (AZT) maintenance for AIDS-related lymphoma: Preliminary results of a multiinstitutional study. Proc Am Soc Clin Oncol 1989 (abstract); 8: 5.

    Google Scholar 

  111. Cheson BD, Levine AM, Mildvan D et al. Suramin therapy in AIDS and related disorders: Report of the US suramin working group. JAMA 1987; 258: 1347–51.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Clinical Oncology Program, National Cancer Institute, Bethesda, MD, 20892, USA

    James M. Pluda M.D., Robert Yarchoan & Samuel Broder

Authors
  1. James M. Pluda M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert Yarchoan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Samuel Broder
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Section of Hematology/Oncology, Department of Medicine, The University of Chicago Cancer Research Center, Chicago, Illinois, USA

    John E. Ultmann  & Brian L. Samuels  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Pluda, J.M., Yarchoan, R., Broder, S. (1991). The occurrence of opportunistic non-Hodgkin’s lymphomas in the setting of infection with the human immunodeficiency virus. In: Ultmann, J.E., Samuels, B.L. (eds) Annals of Oncology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-7305-4_31

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-7305-4_31

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-7294-1

  • Online ISBN: 978-1-4899-7305-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation